v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net income $ 727.2 $ 808.7
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 123.2 126.9
Stock-based compensation expense 257.4 255.7
Gains on marketable and other securities, net (25.0) (139.9)
Other, net 55.6 3.2
Deferred income taxes (96.0) (139.1)
Changes in assets and liabilities:    
Decrease in accounts receivable 1.2 657.8
Decrease (increase) in inventories 26.6 (152.3)
Increase in prepaid expenses and other assets (198.6) (179.5)
Increase in deferred revenue 99.6 17.7
Increase (decrease) in accounts payable, accrued expenses, and other liabilities 107.7 (214.1)
Total adjustments 351.7 236.4
Net cash provided by operating activities 1,078.9 1,045.1
Cash flows from investing activities:    
Purchases of marketable and other securities (2,755.9) (2,539.3)
Sales or maturities of marketable and other securities 2,606.5 3,458.3
Capital expenditures (230.6) (229.3)
Payments for intangible assets (48.9) (42.2)
Net cash (used in) provided by investing activities (428.9) 647.5
Cash flows from financing activities:    
Proceeds from issuance of Common Stock 163.1 60.6
Payments in connection with Common Stock tendered for employee tax obligations (73.2) (4.3)
Repurchases of Common Stock (794.3) (1,041.4)
Dividends paid (97.8) (93.8)
Other 0.0 (10.3)
Net cash used in financing activities (802.2) (1,089.2)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (0.9) 0.6
Net (decrease) increase in cash, cash equivalents, and restricted cash (153.1) 604.0
Cash, cash equivalents, and restricted cash at beginning of period 3,123.7 2,489.0
Cash, cash equivalents, and restricted cash at end of period $ 2,970.6 $ 3,093.0